Sujana Biotech, LLC
- UEI
- RK35KB4LZN97
- CAGE
- 7BCN9
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Selective inhibition of platelet gpib-alpha binding to leukocyte MAC-1 as a therapeutic for multiple sclerosis | National Institute of Neurological Disorders and Stroke | $0 | |
| Vita 2 - developing an anti-thrombotic monoclonal antibody (MAB) with improved safety and efficacy | National Heart Lung and Blood Institute | $783,488 |
Quick answers
What is Sujana Biotech, LLC's UEI?
Sujana Biotech, LLC's Unique Entity ID (UEI) in SAM.gov is RK35KB4LZN97.
What is Sujana Biotech, LLC's CAGE code?
Sujana Biotech, LLC's CAGE code is 7BCN9.
What is Sujana Biotech, LLC's primary NAICS code?
Sujana Biotech, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Sujana Biotech, LLC registered in SAM.gov?
Sujana Biotech, LLC's SAM.gov registration expired on February 25, 2020.
What is Sujana Biotech, LLC's most recent federal award?
Sujana Biotech, LLC's most recent federal grant award is Selective inhibition of platelet gpib-alpha binding to leukocyte MAC-1 as a therapeutic for multiple sclerosis (R43NS105530), from National Institute of Neurological Disorders and Stroke, on September 30, 2018.
On GovTribe
See Sujana Biotech, LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors